Tree nut consumption may lower risk of cardiovascular disease

November, 2015

A meta-analysis of 61 controlled trials has concluded that consuming tree nuts, such as walnuts, lowers total cholesterol, triglycerides, LDL cholesterol, and ApoB, the primary protein found in LDL cholesterol. Walnuts were investigated in 21 of the 61 trials, more than any other nut reviewed.

Consuming at least two servings (two ounces) per day of tree nuts had stronger effects on total cholesterol and LDL. The evidence also suggests that tree nut consumption may be particularly important for lowering the risk of heart disease in individuals with type 2 diabetes.

Walnuts have also been shown to reduce inflammation, and improve arterial function.

http://www.eurekalert.org/pub_releases/2015-11/es-sft111815.php

Del Gobbo, L., Falk, M.C., Feldman, R., Lewis, K., Mozaffarian, D. Effects of tree nuts on blood lipids, apolipoproteins, and blood pressure: systematic review, meta-analysis and dose-response of 61 controlled intervention trials. Am J Clin Nutr.2015; doi: 10.3945/ajcn.115.110965.

Kris-Etherton P. Walnuts decrease risk of cardiovascular disease: a summary of efficacy and biologic mechanisms. J Nutr. 2014; 10.39:2S-8S.

Zhao G, Etherton TD, Martin KR, et al. Dietary alpha-linolenic acid reduces inflammatory and lipid cardiovascular risk factors in hypercholesterolemic men and women. J Nutr 2004; 134: 2991-2997.

Related News

A Finnish study involving over 1000 older adults suggests that a counselling program can prevent cognitive decline even among those with the Alzheimer’s gene.

A pilot study involving 106 participants of the Rush Memory and Aging Project who had experienced a stroke followed participants for an average of 5.9 years, testing their cognitive function and monitoring their eating habits using food journals.

A small study involving 50 younger adults (18-35; average age 24) has found that those with a higher BMI performed significantly worse on a computerised memory test called the “Treasure Hunt Task”.

Another study adds to the growing evidence that a Mediterranean diet is good for the aging brain.

A two-year study which involved metabolic testing of 50 people, suggests that Alzheimer's disease consists of three distinct subtypes, each one of which may need to be treated differently. The finding may help explain why it has been so hard to find effective treatments for the disease.

More evidence for the benefits of the Mediterranean diet for fighting age-related cognitive decline comes from a large 5-year study. The study involved 960 older adults, whose cognitive change was assessed over 4.7 years.

Glucose levels linked to cognitive decline in those with

Data from the population-based Finnish Cardiovascular Risk Factors, Aging and Incidence of Dementia (CAIDE) study has revealed that healthy dietary choices in midlife may prevent dementia in later years. Out of 2,000 participants, 1,449 took part in the follow-up.

Following on from the evidence that Alzheimer’s brains show higher levels of metals such as iron, copper, and zinc, a mouse study has found that amyloid plaques in Alzheimer’s-like brains with significant neurodegeneration have about 25% more copper than those with little neurodegeneration.

Data from the very large U.S. National Health and Nutrition Examination Survey (NHANES), involving 23,168 people, has found a significant association between low dietary fiber intake and risk of metabolic syndrome, cardiovascular inflammation, and obesity.

Pages

Subscribe to Latest newsSubscribe to Latest newsSubscribe to Latest health newsSubscribe to Latest news